Robinhood Asset Management LLC Purchases New Shares in Intuitive Surgical, Inc. $ISRG

Robinhood Asset Management LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,437 shares of the medical equipment provider’s stock, valued at approximately $6,478,000.

Other institutional investors have also added to or reduced their stakes in the company. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the period. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $27,000. Olistico Wealth LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Caitlin John LLC bought a new stake in Intuitive Surgical during the third quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 2,362 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 0.1%

NASDAQ:ISRG opened at $452.58 on Tuesday. The company has a market cap of $160.72 billion, a PE ratio of 57.36, a price-to-earnings-growth ratio of 3.49 and a beta of 1.68. The company has a 50 day simple moving average of $485.91 and a two-hundred day simple moving average of $514.33. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The company’s revenue was up 18.8% compared to the same quarter last year. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Robert W. Baird dropped their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Argus reduced their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Finally, Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $611.77.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.